extract: 2026-03-18-interlune-excavator-full-scale-prototype

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>

domains/space-development/power is the binding constraint on all space operations because every capability from ISRU to manufacturing to life support is power-limited.md

@@ -30,6 +30,12 @@ Astrobotic's LunaGrid is the first commercial attempt to solve the lunar power c
 
 LunaGrid-Lite completed CDR in August 2025 and is fabricating flight hardware for a mid-2026 lunar deployment. The system will demonstrate 1 kW power transmission over 500m of cable. However, the scaling roadmap reveals a critical gap: 1 kW demo (2026) → 10 kW VSAT (2028) → 50 kW VSAT-XL (later). Commercial-scale He-3 extraction requires ~1.2 MW based on Interlune's excavator specs (100 tonnes/hour at 10x less power than 12 MW heat-based systems). This creates a 5-7 year gap between LunaGrid's demonstration capability and extraction-scale power requirements, making power availability a binding constraint on the 2029 pilot plant timeline unless supplemented by nuclear fission surface power.
 
+
+### Additional Evidence (extend)
+*Source: [[2026-03-18-interlune-excavator-full-scale-prototype]] | Added: 2026-03-18*
+
+Interlune's full-scale lunar excavator prototype processes 100 metric tons of regolith per hour, but the press release emphasizes 'reduced power consumption' without providing specific kW requirements. This creates an observable gap between demonstrated hardware capability (excavation throughput) and the power infrastructure needed to operate it continuously. LunaGrid's 1kW demonstration scale is orders of magnitude below what continuous 100-tonne/hour excavation would require, making power the binding constraint on whether this hardware can actually operate as designed.
+
 ---
 
 Relevant Notes:

domains/space-development/the space manufacturing killer app sequence is pharmaceuticals now ZBLAN fiber in 3-5 years and bioprinted organs in 15-25 years each catalyzing the next tier of orbital infrastructure.md

@@ -32,6 +32,12 @@ Each tier depends on unproven assumptions. Pharma depends on some polymorphs bei
 
 **Temporal overlap evidence (2026-01-29):** Varda opened a 10,000 sq ft biologics lab in El Segundo in 2026 specifically for monoclonal antibody processing, which is a complex biologics capability that straddles the pharmaceutical and bioprinting tiers. This suggests the tier boundaries may be more overlapping in execution than strictly sequential—companies may develop capabilities across multiple tiers simultaneously rather than waiting for one to mature before starting the next. The economic logic (each tier funds the next through revenue) may still hold, but the temporal execution appears to be overlapping development rather than strict succession. Varda's AFRL Prometheus contract provides government revenue to fund biologics R&D without waiting for pharmaceutical revenue to scale first, enabling parallel tier development via alternative bootstrap mechanisms (government demand floors rather than commercial revenue). However, this is based on announced intent and lab opening, not demonstrated orbital biologics processing, so the claim remains speculative. This enrichment suggests the three-tier sequence is robust as an economic model but may execute with more temporal overlap than the original thesis implied, especially when government contracts provide alternative funding mechanisms.
 
+
+### Additional Evidence (extend)
+*Source: [[2026-03-18-interlune-excavator-full-scale-prototype]] | Added: 2026-03-18*
+
+Helium-3 extraction represents a fourth commercial track that doesn't fit the existing pharmaceutical→fiber→organs sequence. Interlune's timeline (2027 resource validation, 2029 pilot plant, early 2030s commercial operation at 10kg He-3/year) runs parallel to but independent of the microgravity manufacturing sequence. This suggests multiple distinct value chains may develop simultaneously rather than a single sequential progression.
+
 ---
 
 Relevant Notes:

inbox/queue/2026-03-18-interlune-excavator-full-scale-prototype.md

@@ -7,10 +7,14 @@ date: 2026-03-18
 domain: space-development
 secondary_domains: []
 format: press-release
-status: unprocessed
+status: enrichment
 priority: high
 tags: [lunar-isru, helium-3, interlune, excavation, space-manufacturing, lunar-resources]
 flagged_for_rio: ["First lunar resource company to demonstrate full-scale hardware — investment/valuation milestone"]
+processed_by: astra
+processed_date: 2026-03-18
+enrichments_applied: ["power is the binding constraint on all space operations because every capability from ISRU to manufacturing to life support is power-limited.md", "the space manufacturing killer app sequence is pharmaceuticals now ZBLAN fiber in 3-5 years and bioprinted organs in 15-25 years each catalyzing the next tier of orbital infrastructure.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -51,3 +55,14 @@ Interlune, in partnership with Vermeer Corporation (global industrial equipment
 PRIMARY CONNECTION: the self-sustaining space operations threshold requires closing three interdependent loops simultaneously -- power water and manufacturing — He-3 extraction doesn't fit the water/power/manufacturing loop, but it's the first commercial resource extraction at full-scale hardware stage
 WHY ARCHIVED: Evidence that commercial He-3 extraction is hardware-credible, not just conceptual; key input for assessing the "He-3 as first viable lunar resource" claim
 EXTRACTION HINT: Focus on the throughput rate (100 tonnes/hour), the Vermeer partnership credibility signal, and the mid-2026 funding gate. Don't conflate hardware prototype with flight-ready hardware.
+
+
+## Key Facts
+- Interlune's excavator prototype is designed to process 100 metric tons of lunar regolith per hour
+- The excavator uses vision sensors and ground-penetrating radar for route planning
+- A robotic arm manages oversized surface rocks
+- Interlune's extraction system has four steps: Excavate → Sort → Extract → Separate
+- Interlune plans a 2027 Resource Development Mission with 50 kg payload for concentration validation and small-scale extraction testing
+- Target timeline: 2029 pilot plant, early 2030s commercial operation at 10 kg He-3/year
+- Vermeer Corporation is a $3B+ Iowa-based industrial equipment manufacturer
+- Interlune built a successful sub-scale excavator prototype in summer 2024